The DOI matches its Crossref record; 442 of the 442 references it cites were found in a registry or an index.
Broad targeting of resistance to apoptosis in cancer
Open accessAbstract
Apoptosis or programmed cell death is natural way of removing aged cells from the body. Most of the anti-cancer therapies trigger apoptosis induction and related cell death networks to eliminate malignant cells. However, in cancer, de-regulated apoptotic signaling, particularly the activation of an anti-apoptotic systems, allows cancer cells to escape this program leading to uncontrolled proliferation resulting in tumor survival, therapeutic resistance and recurrence of cancer. This resistance is a complicated phenomenon that emanates from the interactions of various molecules and signaling pathways. In this comprehensive review we discuss the various factors contributing to apoptosis resistance in cancers. The key resistance targets that are discussed include (1) Bcl-2 and Mcl-1 proteins; (2) autophagy processes; (3) necrosis and necroptosis; (4) heat shock protein signaling; (5) the proteasome pathway; (6) epigenetic mechanisms; and (7) aberrant nuclear export signaling. The shortcomings of current therapeutic modalities are highlighted and a broad spectrum strategy using approaches including (a) gossypol; (b) epigallocatechin-3-gallate; (c) UMI-77 (d) triptolide and (e) selinexor that can be used to overcome cell death resistance is presented. This review provides a roadmap for the design of successful anti-cancer strategies that overcome resistance to apoptosis for better therapeutic outcome in patients with cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Items 201–400 of 442
Duval, M., Bœuf, F. L., Huot, J., & Gratton, J. (2007) · Molecular Biology of the Cell · doi:10.1091/mbc.e07-05-0467 · Cited by 143
Masuda, Y., Shima, G., Aiuchi, T., Horie, M., Hori, K., Nakajo, S., Kajimoto, S., Shibayama‐Imazu, T., & Nakaya, K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404256200 · Cited by 142
The Proteasome Is Involved in Angiogenesis
Oikawa, T., Sasaki, T., Nakamura, M., Shimamura, M., Tanahashi, N., Ōmura, S., & Tanaka, K. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8604 · Cited by 139
Mi, L., Wang, X., Govind, S., Hood, B. L., Veenstra, T. D., Conrads, T. P., Saha, D. T., Goldman, R., & Chung, F. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0340 · Cited by 139
Zhen, Y., Liu, Z., Yang, H., Yu, X., Wu, Q., Hua, S., Long, X., Jiang, Q., Song, Y., Cheng, C., et al. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.376 · Cited by 138
Self-citationNuclear Organization and Genome Function
Bortle, K. V., & Corces, V. G. (2012) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-101011-155824 · Cited by 138
Mrowietz, U., Schwenk, U., Maune, S., Bartels, J., Küpper, M., Fichtner, I., Schröder, J., & Schadendorf, D. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690164 · Cited by 137
Identification of human cancer-related genes by naturally occurring Hepatitis B Virus DNA tagging
Gözüaçık, D., Murakami, Y., Saigo, K., Chami, M., Mugnier, C., Lagorce, D., Okanoue, T., Urashima, T., Bréchot, C., & Paterlini-Bréchot, P. (2001) · Oncogene · doi:10.1038/sj.onc.1204835 · Cited by 136
Niebler, M., Qian, X., Höfler, D., Kogosov, V., Kaewprag, J., Kaufmann, A. M., Ly, R., Böhmer, G., Zawatzky, R., Rösl, F., et al. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003536 · Cited by 135
Manero, F., Gautier, F., Gallenne, T., Cauquil, N., Gree, D. M., Cartron, P., Geneste, O., Gree, R. L., Vallette, F. M., & Juin, P. P. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2097 · Cited by 135
Targeting NFKB by autophagy to polarize hepatoma-associated macrophage differentiation
Chang, C., Su, Y.-C., Lee, P.-H., & Lei, H.-Y. (2013) · Autophagy · doi:10.4161/auto.23546 · Cited by 134
Gossypol, a BH3 mimetic, induces apoptosis in chronic lymphocytic leukemia cells
Balakrishnan, K., Wierda, W. G., Keating, M. J., & Gandhi, V. V. (2008) · Blood · doi:10.1182/blood-2007-12-126946 · Cited by 133
Huang, W., He, T., Chai, C., Yang, Y., Zheng, Y., Zhou, P., Qiao, X., Zhang, B., Liu, Z., Wang, J., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037693 · Cited by 133
Choan, E., SEGAL, R. J., Jonker, D. J., Malone, S. C., Reaume, N., Eapen, L. J., & Gallant, V. (2005) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2004.10.008 · Cited by 133
Billard, C., Izard, J., Roman, V., Kern, C., Mathiot, C., Mentz, F., & Kolb, J. (2002) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/1042819021000015952 · Cited by 133
Multidrug Resistance in Cancer
Baguley, B. C. (2009) · Methods in molecular biology · doi:10.1007/978-1-60761-416-6_1 · Cited by 133
Booy, E. P., Henson, E. S., & Gibson, S. B. (2011) · Oncogene · doi:10.1038/onc.2010.616 · Cited by 132
Gossypol Treatment of Recurrent Adult Malignant Gliomas
Bushunow, P. W., Reidenberg, M. M., Wasenko, J. J., Winfield, J. A., Lorenzo, B. J., Lemke, S., Himpler, B., Corona, R. J., & Coyle, T. (1999) · Journal of Neuro-Oncology · doi:10.1023/a:1006267902186 · Cited by 131
Yang, Y., Ikezoe, T., Saito, T., Kobayashi, M., Koeffler, H. P., & Taguchi, H. (2004) · Cancer Science · doi:10.1111/j.1349-7006.2004.tb03200.x · Cited by 131
Cai, J., Ahmad, S., Jiang, W. G., et al. (2003) · Diabetes · doi:10.2337/diabetes.52.12.2959 · Cited by 131
Pan, X., Zhang, X., Sun, H., Zhang, J., Yan, M., & Zhang, H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056679 · Cited by 130
Extra c-myc oncogene copies in high risk cutaneous malignant melanoma and melanoma metastases
Kraehn, G., Utikal, J. S., Udart, M., Greulich, K. M., Bezold, G., Kaskel, P., Leiter, U., & Peter, R. U. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2000.1535 · Cited by 128
Zhu, H., Wang, D., Liu, Y., Su, Z., Zhang, L., Chen, F., Zhou, Y., Wu, Y., Yu, M., Zhang, Z., et al. (2013) · Cancer Cell International · doi:10.1186/1475-2867-13-119 · Cited by 127
Leptomycins A and B, new antifungal antibiotics. II. Structure elucidation.
Hamamoto, T., Seto, H., & Beppu, T. (1983) · The Journal of Antibiotics · doi:10.7164/antibiotics.36.646 · Cited by 127
Why Does Threonine, and Not Serine, Function as the Active Site Nucleophile in Proteasomes?
Kisselev, A. F., Songyang, Z., & Goldberg, A. L. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.20.14831 · Cited by 126
Natural isothiocyanates: Genotoxic potential versus chemoprevention
Fimognari, C., Turrini, E., Ferruzzi, L., Lenzi, M., & Hrelia, P. (2011) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2011.12.001 · Cited by 126
Self-citationChandarlapaty, S., Scaltriti, M., Angelini, P. D., Ye, Q., Guzmán, M., Hudis, C. A., Norton, L., Solit, D. B., Arribas, J., Baselga, J. M., et al. (2009) · Oncogene · doi:10.1038/onc.2009.337 · Cited by 126
Inhibition of P-glycoprotein function by tea catechins in KB-C2 cells
Kitagawa, S., Nabekura, T., & Kamiyama, S. (2004) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357044003 · Cited by 126
(-)-Epigallocatechin-3-gallate downregulates Pg-P and BCRP in a tamoxifen resistant MCF-7 cell line
Farabegoli, F., Papi, A., Bartolini, G., Ostan, R., & Orlandi, M. (2010) · Phytomedicine · doi:10.1016/j.phymed.2010.01.001 · Cited by 123
Non‐peptidic small molecule inhibitors against Bcl‐2 for cancer therapy
Azmi, A. S., & Mohammad, R. M. (2008) · Journal of Cellular Physiology · doi:10.1002/jcp.21567 · Cited by 123
Self-citationHallaert, D. Y. H., Jaspers, A., van Noesel, C. J. M., van Oers, M. H. J., Kater, A. P., & Eldering, E. (2008) · Blood · doi:10.1182/blood-2008-03-146704 · Cited by 123
Ghosh, A. K., Kay, N. E., Secreto, C. R., & Shanafelt, T. D. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1511 · Cited by 123
Bernard, D., Quatannens, B., Vandenbunder, B., & Abbadie, C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011183200 · Cited by 121
p53 and ARF: unexpected players in autophagy
Balaburski, G. M., Hontz, R. D., & Murphy, M. E. (2010) · Trends in Cell Biology · doi:10.1016/j.tcb.2010.02.007 · Cited by 121
Sharma, N., Thomas, S., Golden, E. B., Hofman, F. M., Chen, T. C., Petasis, N. A., Schönthal, A. H., & Louie, S. G. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.07.029 · Cited by 121
Nuclear export is essential for the tumor‐promoting activity of survivin
Knauer, S. K., Krämer, O. H., Knösel, T., Engels, K., Rödel, F., Kovács, A. F., Dietmaier, W., Klein‐Hitpaß, L., Habtemichael, N., Schweitzer, A., et al. (2006) · The FASEB Journal · doi:10.1096/fj.06-5741com · Cited by 121
Zhao, M., Ma, J., Zhu, H., Zhang, X., Du, Z., Xu, Y.-J., & Yu, X.-D. (2011) · Molecular Cancer · doi:10.1186/1476-4598-10-104 · Cited by 121
Chio, C. C., Lin, J., Cheng, H. A., Chiu, W., Wang, Y., Wang, J. J., Hsing, C., & Chen, R. (2012) · Archives of Toxicology · doi:10.1007/s00204-012-0965-5 · Cited by 119
Wolter, K. G., Wang, S. J., Henson, B. S., et al. (2006) · Neoplasia · doi:10.1593/neo.05691 · Cited by 119
Azmi, A. S., Aboukameel, A., Bao, B., Sarkar, F. H., Philip, P. A., Kauffman, M. G., Shacham, S., & Mohammad, R. M. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.10.036 · Cited by 116
Self-citationThe Emerging “Hallmarks” of Metabolic Reprogramming and Immune Evasion: Distinct or Linked?
Kareva, I., & Hahnfeldt, P. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3696 · Cited by 115
Tinhofer, I., Marschitz, I., Kos, M., Henn, T., Egle, A., Villunger, A., & Greil, R. (1998) · Blood · doi:10.1182/blood.v91.11.4273 · Cited by 114
Mi, L., Gan, N., Cheema, A. K., Dakshanamurthy, S., Wang, X., Yang, D. C. H., & Chung, F. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m901789200 · Cited by 113
Merdzhanova, G., Edmond, V., Seranno, S. D., Broeck, A. V. D., Corcos, L., Brambilla, C., Brambilla, E. M., Gazzéri, S., & Eymin, B. (2008) · Cell Death and Differentiation · doi:10.1038/cdd.2008.135 · Cited by 113
Emerging Bcl-2 inhibitors for the treatment of cancer
Azmi, A. S., Wang, Z. P., Philip, P. A., Mohammad, R. M., & Sarkar, F. H. (2010) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.2010.515210 · Cited by 113
Self-citationRIP1-Dependent and Independent Effects of Necrostatin-1 in Necrosis and T Cell Activation
Cho, Y., McQuade, T. J., Zhang, H., Zhang, J., & Chan, F. K.-M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023209 · Cited by 112
Aberrant splicing but not mutations of TSG101 in human breast cancer.
Lee, M. P., & Feinberg, A. P. (1997) · PubMed · Cited by 111
Core signaling pathways of survival/death in autophagy-related cancer networks
Wang, S., Yu, Q., Zhang, R., & Liu, B. (2011) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2011.05.010 · Cited by 111
FAP-1 Association with Fas (Apo-1) Inhibits Fas Expression on the Cell Surface
Ivanov, V. N., Lopez‐Bergami, P., Maulit, G., Sato, T., Sassoon, D. A., & Ronai, Z. A. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.10.3623-3635.2003 · Cited by 111
Farrand, L., Byun, S., Kim, J. Y., Im-Aram, A., Lee, J. H., Lim, S., Lee, K. W., Suh, J., Lee, H. J., & Tsang, B. K. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.487686 · Cited by 110
Cheng, Y., Holloway, M. P., Nguyen, K., McCauley, D., Landesman, Y., Kauffman, M. G., Shacham, S., & Altura, R. A. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0416 · Cited by 110
O’Connell, J., Bennett, M. W., Nally, K., Houston, A. M., O’Sullivan, G. C., & Shanahan, F. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06708.x · Cited by 109
Edwards, J. G., Swinson, D., Jones, J. L., Muller, S., Waller, D. A., & O'Byrne, K. J. (2003) · CHEST Journal · doi:10.1378/chest.124.5.1916 · Cited by 109
To the pore and through the pore: A story of mRNA export kinetics
Oeffinger, M., & Zenklusen, D. (2012) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2012.02.011 · Cited by 108
Small-Molecule XIAP Inhibitors Enhance γ-Irradiation-Induced Apoptosis in Glioblastoma
Vellanki, S. H., Grabrucker, A. M., Liebau, S., Proepper, C., Eramo, A., Braun, V., Boeckers, T. M., Debatin, K., & Fulda, S. (2009) · Neoplasia · doi:10.1593/neo.09436 · Cited by 107
Paclitaxel for non-small cell lung cancer
Ramalingam, S., & Belani, C. P. (2004) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.5.8.1771 · Cited by 107
Chandra, A., Lan, S., Zhu, J., Siclari, V. A., & Qin, L. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.447250 · Cited by 107
Chen, T. C., Wang, W., Golden, E. B., Thomas, S., Sivakumar, W., Hofman, F. M., Louie, S. G., & Schönthal, A. H. (2011) · Cancer Letters · doi:10.1016/j.canlet.2010.11.008 · Cited by 107
Expression of splicing factors in human ovarian cancer
Fischer, D., Noack, K., Runnebaum, I. B., Watermann, D. O., Kieback, D., Stamm, S., & Stickeler, E. (2004) · Oncology Reports · doi:10.3892/or.11.5.1085 · Cited by 106
Deconstructing breast cancer cell biology and the mechanisms of multidrug resistance
Videira, M., Reis, R. L., & Brito, M. A. (2014) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2014.07.011 · Cited by 106
Seki, N., Hayakawa, Y., Brooks, A. D., Wine, J. W., Wiltrout, R. H., Yagita∥, H., Tanner, J. E., Smyth, M. J., & Sayers, T. J. (2003) · PubMed · Cited by 106
Chang, D.-J., An, H., Kim, K.-S., Kim, H. H., Jung, J., Lee, J. M., Kim, N., Han, Y. T., Yun, H., Lee, S.-J., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm301488q · Cited by 102
Inhibition of 6-phosphofructo-2-kinase (PFKFB3) induces autophagy as a survival mechanism
Klarer, A. C., O’Neal, J., Imbert-Fernandez, Y., Clem, A. L., Ellis, S. R., Clark, J. A., Clem, B. F., Chesney, J. A., & Telang, S. (2014) · Cancer & Metabolism · doi:10.1186/2049-3002-2-2 · Cited by 102
Characterization of autostimulatory and transforming growth factors from human melanoma cells.
Richmond, A. J., Lawson, D. H., Nixon, D. W., & Chawla, R. K. (1985) · PubMed · Cited by 101
The role of Bcl-2 family proteins in chronic lymphocytic leukaemia
Buggins, A. G. S., & Pepper, C. J. (2010) · Leukemia Research · doi:10.1016/j.leukres.2010.03.011 · Cited by 101
Structural Basis of High‐Affinity Nuclear Localization Signal Interactions with Importin‐α
Marfori, M., Lonhienne, T. G. A., Forwood, J. K., & Kobe, B. (2012) · Traffic · doi:10.1111/j.1600-0854.2012.01329.x · Cited by 100
Advances in and applications of proteasome inhibitors
Moore, B. S., Eustáquio, A. S., & McGlinchey, R. P. (2008) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2008.06.033 · Cited by 100
Kim, S. M., Yun, M. R., Hong, Y. K., Solca, F., Kim, J.-H., Kim, H. J., & Cho, B. C. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-1188 · Cited by 100
Gundala, S. R., Yang, C., Mukkavilli, R., Paranjpe, R., Brahmbhatt, M., Pannu, V., Cheng, A. S., Reid, M. D., & Aneja, R. (2014) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2014.07.012 · Cited by 99
Novel selective inhibitors of nuclear export CRM1 antagonists for therapy in mantle cell lymphoma
Zhang, K., Wang, M. L., Tamayo, A. T., Shacham, S., Kauffman, M. G., Lee, J., Zhang, L., Ou, Z., Li, C., Sun, L., et al. (2012) · Experimental Hematology · doi:10.1016/j.exphem.2012.09.002 · Cited by 98
Karmakar, S., Banik, N. L., & Ray, S. K. (2007) · Cancer · doi:10.1002/cncr.23223 · Cited by 97
Self-citationElter, T., Gercheva, L., Pylylpenko, H., Robak, T., Jaksic, B. S., Rekhtman, G. B., Kyrcz‐Krzemień, S., Vatutin, M. T., Wu, J., Sirard, C. A., et al. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70242-x · Cited by 97
Lestini, B. J., Goldsmith, K. C., Fluchel, M. N., Liu, X., Chen, N., Goyal, B., Pawel, B., & Hogarty, M. D. (2009) · Cancer Biology & Therapy · doi:10.4161/cbt.8.16.8964 · Cited by 96
Autophagy Protects against Oxaliplatin-Induced Cell Death via ER Stress and ROS in Caco-2 Cells
Shi, Y., Tang, B., Yu, P.-W., Tang, B., Hao, Y., Lei, X., Luo, H.-X., & Zeng, D.-Z. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051076 · Cited by 96
Nucleo-Cytoplasmic Transport of Proteins as a Target for Therapeutic Drugs
Yashiroda, Y., & Yoshida, M. (2003) · Current Medicinal Chemistry · doi:10.2174/0929867033457791 · Cited by 95
Antileukemic Activity of Shepherdin and Molecular Diversity of Hsp90 Inhibitors
Gyurkocza, B., Plescia, J., Raskett, C. M., Garlick, D. S., Lowry, P. A., Carter, B. Z., Andreeff, M., Meli, M., Colombo, G., & Altieri, D. C. (2006) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djj300 · Cited by 94
Buggins, A. G. S., Pepper, C. J., Patten, P., Hewamana, S., Gohil, S. H., Moorhead, J., Folarin, N., Yallop, D., Thomas, N. S. B., Mufti, G. J., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1634 · Cited by 94
Singh, T., Sharma, S. D., & Katiyar, S. K. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027444 · Cited by 94
Koga, F., Kihara, K., & Neckers, L. (2009) · PubMed · Cited by 94
Phase I study of green tea extract in patients with advanced lung cancer
Laurie, S. A., Miller, V. A., Grant, S. C., Kris, M. G., & Ng, K. (2004) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-004-0859-1 · Cited by 93
Cancer Preventive Efficacy of Marine Carotenoid Fucoxanthin: Cell Cycle Arrest and Apoptosis
Rengarajan, T., Rajendran, P., Nandakumar, N., Balasubramanian, M. P., & Nishigaki, I. (2013) · Nutrients · doi:10.3390/nu5124978 · Cited by 93
Targeted Therapy for Malignant Glioma Patients: Lessons Learned and the Road Ahead
Huang, T., Sarkaria, S. M., Cloughesy, T. F., & Mischel, P. S. (2009) · Neurotherapeutics · doi:10.1016/j.nurt.2009.04.008 · Cited by 93
Trisciuoglio, D., Iervolino, A., Zupi, G., & Bufalo, D. D. (2005) · Molecular Biology of the Cell · doi:10.1091/mbc.e04-12-1087 · Cited by 93
Antitumor activity of phenethyl isothiocyanate in HER2-positive breast cancer models
Gupta, P., & Srivastava, S. (2012) · BMC Medicine · doi:10.1186/1741-7015-10-80 · Cited by 92
Ubiquitin-dependent protein degradation: a cellular perspective
Jentsch, S. (1992) · Trends in Cell Biology · doi:10.1016/0962-8924(92)90013-d · Cited by 91
Hu, T., Zhang, C., Tang, Q., Su, Y., Li, B., Chen, L., Zhang, Z., Cai, T., & Zhu, Y. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-251 · Cited by 91
Deng, Y., & Lin, J. (2011) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf204149c · Cited by 91
The fate of epithelial cells in the human large intestine
Barkla, D. H., & Gibson, P. R. (1999) · Pathology · doi:10.1080/003130299105043 · Cited by 90
Lenardo, M. J., Angleman, S. B., Bounkeua, V., Dimas, J., Duvall, M. G., Graubard, M. B., Hornung, F., Selkirk, M. C., Speirs, C. K., Trageser, C., et al. (2002) · Journal of Virology · doi:10.1128/jvi.76.10.5082-5093.2002 · Cited by 90
Cheng, P., Ni, Z., Dai, X., Wang, B., Ding, W., Smith, A. R., Xu, L., Wu, D., He, F., & Lian, J. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.17 · Cited by 88
Spiegl‐Kreinecker, S., Pirker, C., Filipits, M., Lötsch, D., Buchroithner, J., Pichler, J., Silye, R., Weis, S., Micksche, M., Fischer, J., et al. (2009) · Neuro-Oncology · doi:10.1093/neuonc/nop003 · Cited by 88
Sprouse, A. A. (2014) · PubMed · doi:10.7912/c2/305 · Cited by 88
Nguyen, V.-T., Lee, J. I., Qian, Z., Li, Y., Kim, K., Heo, S., Jeon, Y., Park, W., Choi, I., Je, J., et al. (2013) · Marine Drugs · doi:10.3390/md12010069 · Cited by 85
Nair, S., Barve, A., Khor, T.-O., Shen, G., Lin, W., Chan, J. Y., Cai, L., & Kong, A. T. (2010) · Acta Pharmacologica Sinica · doi:10.1038/aps.2010.147 · Cited by 85
Molecular mechanism of pancreatic cancer—understanding proliferation, invasion, and metastasis
Mihaljević, A. L., Michalski, C. W., Friess, H., & Kleeff, J. H. (2010) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-010-0622-5 · Cited by 84
Wang, Z. P., Azmi, A. S., Ahmad, A., Banerjee, S., Wang, S., Sarkar, F. H., & Mohammad, R. M. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3060 · Cited by 83
Self-citationBalakumaran, B. S., Porrello, A., Hsu, D. S., Glover, W., Foye, A., Leung, J. Y., Sullivan, B. A., Hahn, W. C., Loda, M. F., & Febbo, P. G. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0910 · Cited by 83
Sun, J., & Liao, J. K. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000147894.22300.4c · Cited by 82
Nicolau-Galmés, F., Asumendi, A., Alonso-Tejerina, E., Pérez‐Yarza, G., Jangi, S.-M., Gardeazábal, J., Arroyo-Berdugo, Y., Careaga, J. M., Díaz-Ramón, J. L., Apraiz, A., et al. (2011) · APOPTOSIS · doi:10.1007/s10495-011-0640-y · Cited by 81
Beesoo, R., Neergheen, V. S., Bhagooli, R., & Bahorun, T. (2014) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2014.03.005 · Cited by 80
Exchanging Interleukin-8 and Melanoma Growth-stimulating Activity Receptor Binding Specificities
Lowman, H. B., Slagle, P. H., DeForge, L. E., Wirth, C. M., Gillece-Castro, B. L., Bourell, J. H., & Fairbrother, W. J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.24.14344 · Cited by 77
Zuo, J., Ishikawa, T., Boutros, S., Xiao, Z., Humtsoe, J. O., & Kramer, R. H. (2010) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-09-0354 · Cited by 77
Kalid, O., Warshaviak, D. T., Shechter, S., Sherman, W., & Shacham, S. (2012) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-012-9611-9 · Cited by 76
Wanka, C., Brucker, D. P., Bähr, O., Ronellenfitsch, M. W., Weller, M., Steinbach, J. P., & Rieger, J. (2011) · Oncogene · doi:10.1038/onc.2011.530 · Cited by 76
den Kamp, C. M. O., LANGEN, R. C. J., Minnaard, R., KELDERS, M. C. J. M., Snepvangers, F. J. M., Hesselink, M. K. C., Dingemans, A. C., & Schols, A. M. W. J. (2011) · Lung Cancer · doi:10.1016/j.lungcan.2011.09.012 · Cited by 75
Necroptosis: Molecular Signalling and Translational Implications
Giampietri, C., Starace, D., Petrungaro, S., Filippini, A., & Ziparo, E. (2014) · International Journal of Cell Biology · doi:10.1155/2014/490275 · Cited by 75
Hui, B., Shi, Y., Ding, Z., Zhou, J., Gu, C., Peng, Y., Yang, H., Liu, W., Shi, G., & Fan, J. (2012) · Cancer · doi:10.1002/cncr.27586 · Cited by 74
Self-citationReversal of cancer multidrug resistance by green tea polyphenols
Mei, Y., Qian, F., Wei, D., & Liu, J. (2004) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357044364 · Cited by 74
Zhang, H.-Y., Zhang, Q.-Y., Zhang, X., Yu, C.-H., Huo, X., Cheng, E., Wang, D. H., Spechler, S., & Souza, R. (2011) · American Journal of Physiology - Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00458.2010 · Cited by 74
Pang, X., Wu, Y., Wu, Y., Lu, B., Chen, J., Wang, J., Yi, Z., Qu, W., & Liu, M. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0936 · Cited by 74
Kazi, A., Wang, Z., Kumar, N., Falsetti, S. C., Chan, T. H., & Dou, Q. P. (2004) · PubMed · Cited by 74
Self-citationStearns, M. E., Amatangelo, M. D., Varma, D. M., et al. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.100330 · Cited by 73
Hsp90 cleavage by an oxidative stress leads to its client proteins degradation and cancer cell death
Beck, R., Verrax, J., Gonze, T., Zappone, M., Pedrosa, R. C., Taper, H. S., Féron, O., & Calderón, P. B. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.10.019 · Cited by 73
Inhibition of GSK-3 Induces Differentiation and Impaired Glucose Metabolism in Renal Cancer
Pal, K., Cao, Y., Gaisina, I. N., Bhattacharya, S., Dutta, S. K., Wang, E., Gunosewoyo, H., Kozikowski, A. P., Billadeau, D. D., & Mukhopadhyay, D. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0681 · Cited by 73
Awan, F. T., Kay, N. E., Davis, M. E., Wu, W., Geyer, S. M., Leung, N., Jelinek, D. F., Tschumper, R. C., Secreto, C. R., Lin, T. S., et al. (2008) · Blood · doi:10.1182/blood-2008-08-173450 · Cited by 71
Arthur, J. C., Lich, J. D., Aziz, R. K., Kotb, M., & Ting, J. P. ‐. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.9.6291 · Cited by 70
Boldogh, I. R., Roy, G., Lee, M. S., Bácsi, A., Hazra, T. K., Bhakat, K. K., Das, G. C., & MITRA, S. P. (2003) · Toxicology · doi:10.1016/j.tox.2003.08.013 · Cited by 70
RNA polymerase – An important molecular target of triptolide in cancer cells
Pan, J. (2010) · Cancer Letters · doi:10.1016/j.canlet.2009.11.018 · Cited by 70
Preclinical assessment of curcumin as a potential therapy for B‐CLL
Everett, P. C., Meyers, J. A., Makkinje, A., Rabbi, M., & Lerner, A. (2006) · American Journal of Hematology · doi:10.1002/ajh.20757 · Cited by 70
Patel, M. P., Masood, A., Patel, P. S., & Chanan-Khan, A. A. (2009) · Current Opinion in Oncology · doi:10.1097/cco.0b013e328331a7a4 · Cited by 69
Shi, X., Miao, S., Wu, Y., Zhang, W., Zhang, X., Ma, H.-Z., Hai-li, X., Feng, J., Wen, A., & Li, Y. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140815655 · Cited by 69
Death from inside out: an overview
Wyllie, A. H. (1994) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.1994.0099 · Cited by 69
Hsu, A., Bruno, R. S., Löhr, C. V., Taylor, A. W., Dashwood, R. H., Bray, T. Μ., & Ho, E. (2010) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2010.04.006 · Cited by 69
Matthew, E. M., Hart, L. S., Astrinidis, A., Navaraj, A., Dolloff, N. G., Dicker, D. T., Henske, E. P., & El-Deiry, W. S. (2009) · Cell Cycle · doi:10.4161/cc.8.24.10800 · Cited by 67
Chang, P., Wang, T., Chang, Y.-T., Chu, C.-Y., Lee, C.-L., Hsu, H.-W., Zhou, T.-A., Wu, Z., Kim, R. H., Desai, S. J., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088556 · Cited by 67
Self-citationZhong, Y., El‐Gamal, D., Dubovsky, J. A., Beckwith, K. A., Harrington, B. K., Williams, K. E., Goettl, V. M., Jha, S., Mo, X. M., Jones, J. A., et al. (2014) · Leukemia · doi:10.1038/leu.2014.9 · Cited by 66
Telomere 3′ overhang‐specific DNA oligonucleotides induce autophagy in malignant glioma cells
Aoki, H., Iwado, E., Eller, M. S., Kondo, Y., Fujiwara, K., Li, G., Hess, K. R., Siwak, D. R., Sawaya, R. A., Mills, G. B., et al. (2007) · The FASEB Journal · doi:10.1096/fj.06-6941com · Cited by 66
Dreyfuss, J. M., Johnson, M. D., & Park, P. J. (2009) · Molecular Cancer · doi:10.1186/1476-4598-8-71 · Cited by 65
Via, L. D., Nardon, C., & Fregona, D. (2012) · Future Medicinal Chemistry · doi:10.4155/fmc.11.187 · Cited by 65
Selective inhibitors of nuclear export for the treatment of non-Hodgkin's lymphomas
Azmi, A. S., Al-Katib, A. M., Aboukameel, A., McCauley, D., Kauffman, M. G., Shacham, S., & Mohammad, R. M. (2013) · Haematologica · doi:10.3324/haematol.2012.074781 · Cited by 65
Self-citationChan, K. C., Ting, C. M., Chan, P. S., Lo, M. C., Lo, K. W., Curry, J. E., Smyth, T., Lee, A. W. M., Ng, W. T., Tsao, G. S., et al. (2013) · Molecular Cancer · doi:10.1186/1476-4598-12-128 · Cited by 64
Phenethyl isothiocyanate sensitizes human cervical cancer cells to apoptosis induced by cisplatin
Wang, X., Govind, S., Sajankila, S. P., Mi, L., Roy, R., & Chung, F. (2011) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201000560 · Cited by 63
Kaminski, B. M., Weigert, A., Brüne, B., Schumacher, M., Wenzel, U., Steinhilber, D., Stein, J. M., & Ulrich, S. (2010) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-010-1413-y · Cited by 62
Wang, X., Hao, M.-W., Dong, K., Fang, L., Ren, J.-H., & Zhang, H. (2009) · Archives of Pharmacal Research · doi:10.1007/s12272-009-1912-8 · Cited by 61
Vitagliano, O., Addeo, R., D’Angelo, V., Indolfi, C., Indolfi, P., & Casale, F. (2013) · Expert Review of Hematology · doi:10.1586/17474086.2013.827415 · Cited by 61
Yang (2010) · Oncology Reports · doi:10.3892/or.2010.1080 · Cited by 61
Challenges of drug resistance in the management of pancreatic cancer
Sheikh, R. M., Walsh, N., CLYNES, M. M., O'Connor, R. A., & McDermott, R. (2010) · Expert Review of Anticancer Therapy · doi:10.1586/era.10.148 · Cited by 61
Valenti, D., Lidia de, B. A. R. I., Manente, G. A., Rossi, L., Mutti, L., Moro, L., & Vacca, R. A. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.07.014 · Cited by 61
Chang, C.-M., Chang, P., Tu, M., Lu, C., Kuo, S., Amagaya, S., Lee, C., JAO, H.-Y., Chen, M. Y., & Yang, J. (2012) · Oncology Reports · doi:10.3892/or.2012.1991 · Cited by 60
Liang, M., & Fu, J. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.05.025 · Cited by 60
Bolesta, E., Pfannenstiel, L. W., Demelash, A., Lesniewski, M. L., Tobin, M., Schlanger, S. E., Nallar, S. C., Papadimitriou, J. C., Kalvakolanu, D. V., & Gastman, B. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.06214-11 · Cited by 60
Syed, N., Coley, H. M., Sehouli, J., Koensgen, D., Mustea, A., Szlosarek, P. W., McNeish, I. A., Blagden, S. P., Schmid, P., Lovell, D. P., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2048 · Cited by 58
Self-citationZhang, C., Cai, T., Zhu, H., Yang, L., Jiang, H., Dong, X., Hu, Y., Lin, N.-M., He, Q., & Yang, B. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-1091 · Cited by 58
Liu, J., Shen, M., Yue, Z., Yang, Z., Wang, M., Li, C., Xin, C., Wang, Y., Mei, Q., & Wang, Z. (2012) · Phytomedicine · doi:10.1016/j.phymed.2012.02.014 · Cited by 56
Nuclear Export Mediated Regulation of MicroRNAs: Potential Target for Drug Intervention
Muqbil, I., Bao, B., Abou‐Samra, A., Mohammad, R. M., & Azmi, A. S. (2013) · Current Drug Targets · doi:10.2174/1389450111314100002 · Cited by 56
Self-citationParrondo, R. D., Pozas, A. D. L., Reiner, T., & Perez‐Stable, C. (2013) · PeerJ · doi:10.7717/peerj.144 · Cited by 56
Siegelin, M. D. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.01.045 · Cited by 56
Self-citationInflammation and survival pathways: Chronic lymphocytic leukemia as a model system
Chen, L. S., Balakrishnan, K., & Gandhi, V. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.07.039 · Cited by 55
Exportin-Mediated Nuclear Export of Proteins and Ribonucleoproteins
Fornerod, M. W. J., & Ohno, M. (2002) · Results and problems in cell differentiation · doi:10.1007/978-3-540-44603-3_4 · Cited by 55
Design of novel BH3 mimetics for the treatment of chronic lymphocytic leukemia
Billard, C. (2012) · Leukemia · doi:10.1038/leu.2012.88 · Cited by 55
Dupéré-Richer, D., Kinal, M., Ménasché, V., Nielsen, T. H., Rincon, S. V. D., Pettersson, F., & Miller, W. H. (2013) · Cell Death and Disease · doi:10.1038/cddis.2012.210 · Cited by 55
Pancreatic intraepithelial neoplasia – can we detect early pancreatic cancer?
Haugk, B. (2010) · Histopathology · doi:10.1111/j.1365-2559.2010.03610.x · Cited by 54
Piekiełko‐Witkowska, A., Wiszomirska, H., Wójcicka, A., Popławski, P., Bogusławska, J., Tański, Z., & Nauman, A. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013690 · Cited by 54
BCL‐2 functions as an activator of the AKT signaling pathway in pancreatic cancer
Mortenson, M. M., Galante, J. G., Gilad, O., et al. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21343 · Cited by 54
Russo, M., Spagnuolo, C., Volpe, S., Mupo, A., Tedesco, I., & Russo, G.-L. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605794 · Cited by 54
Self-citationKumar, P., Yu, N., & Polverini, P. J. (2008) · Laboratory Investigation · doi:10.1038/labinvest.2008.46 · Cited by 54
Glioblastoma multiforme: a rare manifestation of extensive liver and bone metastases
Robert, M. E., & Wastie, M. L. (2008) · Biomedical Imaging and Intervention Journal · doi:10.2349/biij.4.1.e3 · Cited by 54
2-Methoxy antimycin reveals a unique mechanism for Bcl-xL inhibition
Schwartz, P. S., Manion, M. K., Emerson, C. B., Fry, J. S., Schulz, C. M., Sweet, I. R., & Hockenbery, D. M. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0767 · Cited by 54
Autophagy in Prostate Cancer and Androgen Suppression Therapy
Ziparo, E., Petrungaro, S., Marini, E. S., Starace, D., Conti, S., Facchiano, A., Filippini, A., & Giampietri, C. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140612090 · Cited by 53
Hu, L., Miao, W., Loignon, M., Kandouz, M., & Batist, G. (2009) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-009-1182-7 · Cited by 53
Shin, E. A., Sohn, E. J., Won, G., Choi, J.-U., Jeong, M., Kim, B., Kim, M., & Kim, S. (2014) · Oncotarget · doi:10.18632/oncotarget.2152 · Cited by 53
Chen, S., Han, Q., Wang, X., Yang, M., Zhang, Z., Li, P., Chen, A., Hu, C., & Li, S. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.380 · Cited by 52
Self-citationBono, C., Karlin, L., Harel, S., Mouly, E., Labaume, S., Galicier, L., Apcher, S., Sauvageon, H., Fermand, J., Bories, J.-C., et al. (2012) · Haematologica · doi:10.3324/haematol.2011.049981 · Cited by 52
The role of the NFκB signalling pathway in cancer
Cortés-Sempere, M., Fanjul, V. R., Sánchez‐Pérez, I., & Perona, R. (2008) · Clinical & Translational Oncology · doi:10.1007/s12094-008-0171-3 · Cited by 51
Proteasome modulates mitochondrial function during cellular senescence
Torres, C. A., & Pérez, V. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.10.002 · Cited by 51
Chen, N., Eritja, N., Lock, R., & Debnath, J. (2013) · Oncogene · doi:10.1038/onc.2012.277 · Cited by 50
Chow, S., Kao, C., Liu, Y.-T. A., Cheng, M., Yang, Y.-W., Huang, Y., Hsu, C., & Wang, J. (2013) · APOPTOSIS · doi:10.1007/s10495-013-0945-0 · Cited by 50
Fimognari, C., Nüsse, M., Lenzi, M., Sciuscio, D., Cantelli‐Forti, G., & Hrelia, P. (2006) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2006.06.001 · Cited by 49
Self-citationTRAIL-mediated signaling in prostate, bladder and renal cancer
Voelkel‐Johnson, C. (2011) · Nature Reviews Urology · doi:10.1038/nrurol.2011.81 · Cited by 48
Dürig, J., Dührsen, U., Klein‐Hitpaß, L., Worm, J., Hansen, J. B. R., Ørum, H., & Wissenbach, M. (2011) · Leukemia · doi:10.1038/leu.2010.322 · Cited by 48
Jackson, R. S., Placzek, W. J., Fernandez, A., Ziaee, S., Chu, C.-Y., Wei, J., Stebbins, J. L., Kitada, S., Fritz, G. A., Reed, J. C., et al. (2012) · Neoplasia · doi:10.1593/neo.12640 · Cited by 47
Ma, J., Sun, Y., Wang, Y., Wu, H., Jin, J., & Yu, X. (2013) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/096504013x13657689382932 · Cited by 47
High-Throughput Screening Fluorescence Polarization Assay for Tumor-Specific Hsp90
Du, Y., Moulick, K., Rodina, A., Aguirre, J., Felts, S. J., Dingledine, R. J., Fu, H., & Chiosis, G. (2007) · SLAS DISCOVERY · doi:10.1177/1087057107306067 · Cited by 47
Das, A., Banik, N. L., & Ray, S. K. (2007) · Journal of Neuro-Oncology · doi:10.1007/s11060-007-9485-1 · Cited by 47
Self-citationZgheib, A., Lamy, S., & Annabi, B. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.456533 · Cited by 46
Proteasome inhibition and ROS generation by 4‐nerolidylcatechol induces melanoma cell death
Brohem, C. A., Massaro, R. R., Tiago, M., Marinho, C. E., Jasiulionis, M. G., de Almeida, R. L., Rivelli, D. P., Albuquerque, R. C., de Oliveira, T. F., Loureiro, A. P. D. M., et al. (2012) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2012.00992.x · Cited by 45
Tucker, C., Kapanen, A. I., Chikh, G., Hoffman, B. G., Kyle, A. H., Wilson, I. M., Masin, D., Gascoyne, R. D., Bally, M. B., & Klasa, R. J. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0302 · Cited by 45
Murdoch, W. J., Wilken, C., & Young, D. A. (1999) · Reproduction · doi:10.1530/jrf.0.1170325 · Cited by 44
Li, X., Wu, W. K. K., Sun, B., Cui, M., Liu, S., Gao, J., & Lou, H. (2010) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2010.12.007 · Cited by 43
Cascone, T., Morelli, M. P., Morgillo, F., Kim, W., Rodolico, G., Pepe, S., Berrino, L., Lee, H., Heymach, J. V., & Ciardiello, F. (2008) · Journal of Cellular Physiology · doi:10.1002/jcp.21444 · Cited by 43
Toluquinol, a marine fungus metabolite, is a new angiosuppresor that interferes the Akt pathway
García‐Caballero, M., Marí‐Beffa, M., Cañedo, L. M., Medina, M. Á., & Quesada, A. R. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.04.007 · Cited by 42
Induction of apoptosis in cancer cell lines by the Red Sea brine pool bacterial extracts
Sagar, S., Esau, L., Holtermann, K., Hikmawan, T., Zhang, G., Stingl, U., Bajic, V. B., & Kaur, M. (2013) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-13-344 · Cited by 41
Bennett, H. L., Stockley, J., Fleming, J., Mandal, R., O’Prey, J., Ryan, K. M., Robson, C. N., & Leung, H. Y. (2012) · British Journal of Urology · doi:10.1111/j.1464-410x.2012.11409.x · Cited by 41
Glucose—a sweet way to die: Metabolic switching modulates tumor cell death
MacFarlane, M., Robinson, G. L., & Cain, K. (2012) · Cell Cycle · doi:10.4161/cc.21804 · Cited by 41
Carter, B. Z., Mak, D. H. F., Shi, Y. X., Fidler, J. M., Chen, R., Ling, X., Plunkett, W. K., & Andreeff, M. (2011) · Leukemia · doi:10.1038/leu.2011.246 · Cited by 40
Hepatotoxicidad por extracto etanólico seco de Camellia sinensis
Pedrós, C., Cereza, G., García, N., & Laporte, J. (2003) · Medicina Clínica · doi:10.1016/s0025-7753(03)74026-3 · Cited by 39
Prognostic role of myeloid cell leukemia‐1 protein (Mcl‐1) expression in human gastric cancer
Wang, L., Qun, L., Wanqing, Z., Haifeng, S., Li, F., & Li, X. (2009) · Journal of Surgical Oncology · doi:10.1002/jso.21344 · Cited by 38
Zheng, L., Yang, W., Zhang, C., Ding, W., Zhu, H., Lin, N.-M., Wu, H., He, Q., & Yang, B. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.05.011 · Cited by 38
Hoffmann, J., Junker, H., Schmieder, A., Venz, S., Brandt, R., Multhoff, G., Falk, W., & Radons, J. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.07.063 · Cited by 38
Choi, H.-N., Jin, H., Kim, J., Hong, S., Kim, H., Kim, E., Lee, J. K., Park, I., & Noh, W. C. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.01.074 · Cited by 38
Nucleo-cytoplasmic communication in apoptotic response to genotoxic and inflammatory stress
Wang, J. Y. J. (2005) · Cell Research · doi:10.1038/sj.cr.7290263 · Cited by 37
Pathology of pancreatic stroma in PDAC
Rasheed, Z. A., Matsui, W. H., & Maitra, A. (2012) · Cited by 36
Chen, S., Fribley, A. M., & Wang, C.-Y. (2002) · Journal of Dental Research · doi:10.1177/0810098 · Cited by 36
Self-citationChopra, M., Lang, I., Salzmann, S., Pachel, C., Kraus, S., Bäuerlein, C. A., Brede, C., Garrote, A.-L. J., Mattenheimer, K., Ritz, M., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075737 · Cited by 36
Small Molecule Inhibitors of Bcl-2 Family Proteins for Pancreatic Cancer Therapy
Masood, A., Azmi, A. S., & Mohammad, R. M. (2011) · Cancers · doi:10.3390/cancers3021527 · Cited by 36
Self-citationZhang, X., Huang, X., Hu, X., Zhan, Y., An, Q., Yang, S., Xia, A.-J., Yi, J., Chen, R., Mu, S., et al. (2010) · Asian Journal of Andrology · doi:10.1038/aja.2010.57 · Cited by 35
Hung, F.-M., Chen, Y., Huang, A., Hsiao, Y., Yang, J., Chung, M.-T., Chueh, F., Lu, H.-F., & Chung, J. (2013) · Oncology Reports · doi:10.3892/or.2013.2230 · Cited by 34
Mozzicafreddo, M., Cuccioloni, M., Cecarini, V., Eleuteri, A. M., & Angeletti, M. (2009) · Journal of Chemical Information and Modeling · doi:10.1021/ci800235m · Cited by 34
Pacák, K., Sirová, M., Giubellino, A., Lencesova, L., Csáderová, L., Lauková, M., Hudecová, S., & Križanová, O. (2012) · International Journal of Cancer · doi:10.1002/ijc.27524 · Cited by 34
Hwang, K.-C., Lee, K.-H., Jang, Y., Yun, Y., & Chung, K.-H. (2002) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200202000-00014 · Cited by 34
Cited by
Tumor biomarkers for diagnosis, prognosis and targeted therapy
Zhou, Y., Tao, L., Qiu, J., Xu, J., Yang, X., Zhang, Y., Tian, X., Guan, X., Cen, X., & Zhao, Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01823-2 · Cited by 720
Self-citationRegulated necrosis: disease relevance and therapeutic opportunities
Conrad, M., Angeli, J. P. F., Vandenabeele, P., & Stockwell, B. R. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2015.6 · Cited by 630
The multi-factorial nature of clinical multidrug resistance in cancer
Assaraf, Y. G., Brozovic, A., Gonçalves, A. C., Jurkovicova, D., Linē, A., Machuqueiro, M., Saponara, S., Sarmento-Ribeiro, A. B., Xavier, C. P. R., & Vasconcelos, M. H. (2019) · Drug Resistance Updates · doi:10.1016/j.drup.2019.100645 · Cited by 528
Vaccination with early ferroptotic cancer cells induces efficient antitumor immunity
Efimova, I., Catanzaro, E., Van der Meeren, L., Turubanova, V. D., Hammad, H., Mishchenko, T. A., Vedunova, M. V., Fimognari, C., Bachert, C., Coppieters, F., et al. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-001369 · Cited by 520
Self-citationOvercoming cancer therapeutic bottleneck by drug repurposing
Zhang, Z., Zhou, L., Xie, N., Nice, E. C., Zhang, T., Cui, Y., & Huang, C. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00213-8 · Cited by 516
Metadata
- Authors
- Mohammad, R. M., Muqbil, I., Lowe, L., Yedjou, C., Hsu, H.-Y., Lin, L.-T., Siegelin, M. D., Fimognari, C., Kumar, N. B., Dou, Q. P., Yang, H., Samadi, A. K., Russo, G. L., Spagnuolo, C., Ray, S. K., Chakrabarti, M., Morre, J. D., Coley, H. M., Honoki, K., Fujii, H., Georgakilas, A. G., Amedei, A., Niccolai, E., Amin, A., Ashraf, S. S., Helferich, W. G., Yang, X., Boosani, C. S., Guha, G., Bhakta, D., Ciriolo, M. R., Aquilano, K., Chen, S., Mohammed, S. I., Keith, W. N., Bilsland, A., Halicka, D., Nowsheen, S., & Azmi, A. S.
- Venue
- Seminars in Cancer Biology
- Publisher
- Elsevier BV
- Published
- 2015-12
- Volume
- 35
- Pages
- S78-S103
- ISSN
- 1044-579X (ISSN-L)
- OpenAlex
- W2072860434
- Cited by
- 864
- References
- 442
- FWCI
- 17.50
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.